Tenofovir Alafenamide
Back to searchMolecule Structure
Scientific Name
Tenofovir Alafenamide
Description of the Drug
Tenofovir alafenamide is a nucleoside analog reverse transcriptase inhibitor used for the treatment of chronic hepatitis B virus infection in adults with compensated liver disease.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB09299
http://www.drugbank.ca/drugs/DB09299
Brand Name(s)
Gs-7340, Vemlidy
Company Owner(s)
Janssen Products Lp, Gilead Sciences Inc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Human immunodeficiency virus type 1 reverse transcriptase | SINGLE PROTEIN | INHIBITOR | CHEMBL247 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL3107149 | ||
DrugBank | DB09299 | ||
PubChem: Thomson Pharma | 152138479 | ||
PubChem | 9574768 | ||
DrugCentral | 4944 | ||
ChemicalBook | CB92627921 | CB42741929 | |
rxnorm | TENOFOVIR ALAFENAMIDE | VEMLIDY | TENOFOVIR ALAFENAMIDE FUMARATE |
ChEBI | 90926 | ||
ZINC | ZINC000100055899 |